Pegtibatinase
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pegtibatinase, covering 2024-11-22 to 2025-04-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) [Phase 3]